Projects per year
Personal profile
Biography
Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the Central Clinical School. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Biography
Links:
- Department of Diabetes: www.med.monash.edu.au/cecs/diabetes/
- Professor Mark Cooper: www.med.monash.edu.au/cecs/diabetes/staff/cooper-mark.html
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Diabetes
- Diabetic Complications
- kidney disease
- heart disease
- blindness
Network
-
Splice switching oligonucleotides for the treatment of chronic kidney disease
Thomas, M., Wilton, S., Wraight, C., Pickering, R., Cooper, M., Coughlan, M., Tesch, G., Kitching, R. & Jupp, B.
1/01/23 → 31/12/25
Project: Research
-
New strategy to safely and effectively reduce diabetic kidney disease
Chai, Z., Chalmers, D. & Cooper, M.
1/01/22 → 31/12/25
Project: Research
-
Predicting Renal, Ophthalmic and Heart Events in the Aboriginal Community: The PROPHECY Diabetes Multi-Omics Cohort Study
Brown, A., Zimmet, P., Cooper, M., Shaw, J., El-Osta, S., Willerslev, E., Maple-Brown, L. J., James, D. E., Nicholls, S. & Craig, J. E.
1/01/22 → 30/06/25
Project: Research
-
-
-
Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice
Hanssen, N. M. J., Tikellis, C., Pickering, R. J., Dragoljevic, D., Lee, M. K. S., Block, T., Scheijen, J. LJM., Wouters, K., Miyata, T., Cooper, M. E., Murphy, A. J., Thomas, M. C. & Schalkwijk, C. G., Feb 2023, In: Biomedicine and Pharmacotherapy. 158, 9 p., 114211.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes
Khurana, I., Kaipananickal, H., Maxwell, S., Birkelund, S., Syreeni, A., Forsblom, C., Okabe, J., Ziemann, M., Kaspi, A., Rafehi, H., Jørgensen, A., Al-Hasani, K., Thomas, M. C., Jiang, G., Luk, A. O., Lee, H. M., Huang, Y., Thewjitcharoen, Y., Nakasatien, S., Himathongkam, T., & 12 others , 15 Feb 2023, In: The Journal of Clinical Investigation. 133, 4, 19 p., e160959.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Thomas, M. C., Coughlan, M. T. & Cooper, M. E., 7 Feb 2023, In: Cell Metabolism. 35, 2, p. 253-273 21 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access1 Citation (Scopus) -
Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
Wang, T., Zhang, J., Wang, Y., Zhao, L., Wu, Y., Ren, H., Zou, Y., Zhang, R., Xu, H., Chai, Z., Cooper, M. E., Zhang, J. & Liu, F., Jan 2023, In: Journal of Clinical Medicine. 12, 1, 13 p., 88.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes
Zhao, L., Han, Q., Zhou, L., Bai, L., Wang, Y., Wu, Y., Ren, H., Zou, Y., Li, S., Su, Q., Xu, H., Li, L., Chai, Z., Cooper, M. E., Tong, N., Zhang, J. & Liu, F., 31 Dec 2022, In: Renal Failure. 44, 1, p. 346-357 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus)
Activities
- 1 Patents
-
Baker Heart and Diabetes Institute (External organisation)
Zhong-Lin Chai (Inventor) & Mark Cooper (Inventor)
29 Jul 2010Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent